Fizzy water eases tummy troubles, study finds
NCT ID NCT05375487
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether drinking natural carbonated mineral water can improve digestion and change gut bacteria in people with mild stomach discomfort. Thirty adults aged 18 to 70 took part. The results may help people find a simple, drug-free way to support regular bowel movements.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Apr 2023
- Finished
-
Nov 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 70 years * History of gastrointestinal discomfort * Not using any laxative drug for 3 days before the screening visit * Drinking 1.0 ± 0.5 L of water per day * Accepting and signing the informed consent Exclusion Criteria: * Treatment or disease (current or past) likely to interfere with evaluation of the study parameters * Taking antibiotics in the 3 months preceding the recruitment visit * Taking supplements or any food enriched with or containing bacteria or yeasts likely to have an effect on the gastrointestinal tract, particularly on intestinal transit, digestive comfort, gas production, or the occurrence of abdominal pain, in the 30 days preceding the recruitment visit (these products will also be banned during the study period) * Subject having an alcohol consumption of more than 3 glasses of wine per day, or 2 glasses of beer per day, or 1 glass of hard liquor per day * Subject having a coffee consumption greater than 5 cups per day * Subject with constipation attributable to an organic or anatomical cause (Hirschsprung's disease, hypothyroidism, mental deficiency, psychiatric illness, neurological abnormalities, history of operation of the colon or anus, colorectal cancer, anemia, etc.) * Subject with a history of current gastrointestinal pathology or disorder such as duodenal ulcer, chronic colitis, or chronic inflammatory disease of the gastrointestinal tract (Crohn's disease, ulcerative colitis), celiac disease, or irritable bowel syndrome * Subject having a history of operation of the digestive tract * Subject having undergone surgery in the two months preceding the recruitment visit * Subject having undergone bariatric surgery * Having participated in a weight loss program (with a 5-10% weight loss) in the last 3 months prior to the recruitment visit * Body mass index \> 35 kg/m² * Taking supplements of magnesium, vitamins, or other minerals during the study period * Intake of other carbonated mineral waters beyond the provided water during the study period * Pregnancy * Participation in another clinical trial during the last 30 days prior to the recruitment visit
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastrointestinal discomfort are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NOVA Medical School | Faculdade de Ciências Médicas da Universidade NOVA
Lisbon, 1169-056, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.